LSI Europe '22

Confirmed Presenting Companies

Aortyx is developing a solution for the treatment of aortic dissection. The company is developing a biomimetic, bioresorbable endovascular patch that is deployed via an endovascular catheter. The patch is designed to cover an aortic tear, stop false lumen blood flow, and promote natural repair and bio-integration at the tear site. 

Visit website.

Jordi  Martorell flag Jordi Martorell, CEO & Co-Founder
Aortyx

In-Person Presenter

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

Visit website.

Stuart Mitchell flag Stuart Mitchell, Founder/CEO
Novuson

In-Person Presenter

NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being. 

Visit website.

Jonathan Berent flag Jonathan Berent, CEO, Founder
NextSense

In-Person Presenter

Designer and manufacturer of medical simulation products.  Core range of simulators includes ‘take-home’ laparoscopic simulators and a range of institutional based laparoscopic simulators. The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.

Visit website.

Elliot Street flag Elliot Street, CEO
Inovus Medical

In-Person Presenter

Paragate Medical is developing an implantable peritoneal ultrafiltration device that functions as a mechanical bypass too the kidneys and maintain fluid balance in patients with kidney or chronic heart failure.

Visit website.

Nitai Hanani flag Nitai Hanani, CEO
Paragate Medical

In-Person Presenter

Onera Health develops diagnostic and monitoring solutions to help people with sleep-related ailments. The company's Onera STS wearable sleep system collects comprehensive sleep data which allows providers to optimize patient care and reduce costs.

Visit website.

Ruben de Francisco flag Ruben de Francisco, CEO
Onera Health

In-Person Presenter

Endoron is developing a long-lasting solution for the treatment of abdominal aortic aneurysm (AAA). The company's Aortoseal system uses a smart stapling system that penetrates the aortic wall and stent graft to secure the graft in place in a variety of anatomies. 

Visit website.

Ronit Harpaz flag Ronit Harpaz, CEO & Co-founder
Endoron Medical

In-Person Presenter

Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.

Visit website

Laura Yecies flag Laura Yecies, CEO
Bone Health Technologies

In-Person Presenter

Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.

Visit website.

Carolina Aguilar flag Carolina Aguilar, CEO
INBRAIN Neuroelectronics

In-Person Presenter

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.

Visit website.

Berk Tas flag Berk Tas, CEO
SentiAR

In-Person Presenter

Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation. 

Visit website.

Christopher Prentice flag Christopher Prentice, CEO
Harmonic Bionics

In-Person Presenter

Smart, flexible, portable, home hemodialysis machine that will enable patients to treat themselves wherever they are.

Visit website.

Osman Khawar flag Osman Khawar, CEO
Diality

In-Person Presenter

BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva. 

Visit website.

Andrew A. Dahl flag Andrew A. Dahl, Founder & Chairman
BioMEMS Diagnostics

In-Person Presenter

A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Visit website.

Philip Rackliffe flag Philip Rackliffe, CEO
Centerline Biomedical

In-Person Presenter

Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along  with devices that accelerate healing, to rapidly close chronic non-healing wounds. The wound management platform consists of a nanotechnology wound gel dressing formulation (HemastylRx) and Gen-Ray, a device to apply mild-heating to the wound to accelerate absorption and stimulate the healing process.

Visit website.

Dr. Margaret Kalmeta flag Dr. Margaret Kalmeta, Founder & CEO
Rapid Nexus

In-Person Presenter

Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.

Visit website.

Susan Trent flag Susan Trent, CEO
Atlantic Therapeutics

In-Person Presenter

inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.

Visit website.

Todor Jeliaskov flag Todor Jeliaskov, President & CEO
inHEART

In-Person Presenter

Cold cap therapy is a commonly used solution to prevent hair loss in patients undergoing chemotherapy. Cooler Heads is developing a novel cold cap system for cancer patients that has been designed to be easier to use and more affordable than existing solutions.

Visit website.

Kate Dilligan flag Kate Dilligan, CEO
Cooler Heads

In-Person Presenter

Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.

Visit website.

Mike Karim flag Mike Karim, CEO
Oxford Endovascular

In-Person Presenter

Locate Bio specializes in the development of orthobiologics for orthopedic surgery. The company's orthobiologic products leverage Locate Bio's expertise in programmed drug release and instructive tissue scaffolds to enhance the tissue repair process.

Visit website.

John von Benecke flag John von Benecke, CEO
Locate Bio

In-Person Presenter

SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers. 

Visit website.

Karen Holzberger flag Karen Holzberger, President & CEO
SpinTech MRI

In-Person Presenter

Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).

Visit website.

Andrew Glass flag Andrew Glass, CEO
Vivasure Medical

In-Person Presenter

NirvaMed is developing a new treatment for ST-Elevation Myocardial Infarction (STEMI) heart attacks that will reduce heart muscle death compared to current treatment options. 

Visit website.

Troy Ziegler flag Troy Ziegler, CEO
NirvaMed

In-Person Presenter

Moon Surgical is developing a surgical robot to assist with laparoscopic surgeries. The system will feature a modular platform, computer vision, and haptics to augment the capabilities of surgeons.  

Visit website.

Anne Osdoit flag Anne Osdoit, CEO
Moon Surgical

In-Person Presenter

NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science. 

Visit website.

Thorsten Waloschek flag Thorsten Waloschek, CEO
NeoPrediX

In-Person Presenter

Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.

Visit website.

Enrique Vega flag Enrique Vega, CEO & Co-founder
Azalea Vision

In-Person Presenter

Accelerating surgical capability for life science businesses via precision VR simulation.

Visit website.

Richard Vincent flag Richard Vincent, Founder & CEO
FundamentalVR

In-Person Presenter

Gradient Denervation Technologies is using thermal ablation to reduce pulmonary pressure in patients with pulmonary hypertension. The technology will target the nerves responsible for the hyperactivity of the pulmonary artery nerves to produce a long-term reduction in pulmonary pressure.

Visit website.

Martin Grasse flag Martin Grasse, CEO
Gradient Denervation Technologies

In-Person Presenter

Surgical solutions that help improve suturing safety, speed and versatility.

Visit website.

Claude Nogard flag Claude Nogard, CEO
Ergosuture

In-Person Presenter

Developing a miniaturized neuromodulation device for therapeutic applications. The company is currently in stealth mode.

Visit website.

Barry Keenan flag Barry Keenan, CEO
Nervonik

In-Person Presenter

Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy. 

Visit website.

Katarina Hedbeck flag Katarina Hedbeck, CEO
Tada Medical

In-Person Presenter

HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.

Visit website.

Peter Kassel flag Peter Kassel, CEO
HealthySole

In-Person Presenter

Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.

Visit website.

Marc Giroux flag Marc Giroux, CEO
Kurve Therapeutics

In-Person Presenter

Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere.  Our patented Q-LAAD technology allows us to develop diagnostics tests without the tradeoff between speed, accuracy, and ease of use inherent in legacy diagnostic testing technologies. Join us to learn more about the diagnostic testing revolution.

Visit website.

Steven Burden flag Steven Burden, CEO
Facible BioDiagnostics

In-Person Presenter

Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.

Visit website.

David Kuraguntla flag David Kuraguntla, CEO
Alio

In-Person Presenter

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.

Visit website.

Bryan Lord flag Bryan Lord, CEO
Pristine Surgical

In-Person Presenter

Software-as-a-service (Saas) platform to manage the clinical trial life cycle. Hawthorne Effect's mission is to make clinical trials accessible and convenient for all parties. 

Visit website.

Jodi Akin flag Jodi Akin, CEO
Hawthorne Effect

In-Person Presenter

Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Visit website.

Lloyd Diamond flag Lloyd Diamond, CEO
Pixium Vision

In-Person Presenter

Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.

Visit website.

Iwan van Vijfeijken flag Iwan van Vijfeijken, CEO
Pulsify Medical

In-Person Presenter

Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.

Visit website.

Manny Villafana flag Manny Villafana, Founder of St. Jude Medical, ATS, Cardiac Pacemakers
Medical 21

In-Person Presenter

SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues. 

Visit website.

Len Pagliaro flag Len Pagliaro, CEO
Siva Therapeutics

In-Person Presenter

MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Visit website.

Charles Allan flag Charles Allan, CEO
MY01

In-Person Presenter

Next-generation beta ophthalmic applicator.

Visit website.

Laurence Marsteller flag Laurence Marsteller, CEO
Radiance Therapeutics

In-Person Presenter

The IntelliSense Drill is an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.

Visit website.

Joseph McGinley flag Joseph McGinley, Founder & CEO
McGinley Orthopedics

In-Person Presenter

Our Clients